Matthew Laughon
Vice Chair of Academic Affairs · University of North Carolina Hospitals
Credentials: · · ·
History
Research
The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach
American Journal of Respiratory and Critical Care Medicine · 2019 · 1,035 citations
Review · Nature Reviews Disease Primers · 2019 · 899 citations
Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants
American Journal of Respiratory and Critical Care Medicine · 2011 · First of 27 authors · Corresponding · 370 citations
64 papers · 1 as a fellow
- RC
57 papers
56 papers · 7 as a fellow
44 papers · 7 as a resident
44 papers · 6 as a resident
33 papers · 4 as a resident
29 papers
28 papers
Grants
- 2001–2030
North Carolina Clinical Center
National Institute of Child Health and Human Development · UG1
PI · $1.4M · Duke University
- 2023–2028
- 2019–2025
Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia
National Heart, Lung, and Blood Institute · R33
PI · $6.8M · Duke University
- 2018–2025
Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary Dysplasia
Food and Drug Administration · R01
Contact PI · $2M · Univ of North Carolina Chapel Hill
Clinical trials
- 2018–2025
Safety of Sildenafil in Premature Infants
Principal investigator · Completed · Phase 2
University of North Carolina, Chapel Hill
- 2015–2019
Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD)
Principal investigator · Completed · Phase 2
University of North Carolina, Chapel Hill
- 2013–2016
Pharmacokinetics of Sildenafil in Premature Infants
Principal investigator · Completed · Phase 1
University of North Carolina, Chapel Hill
- 2011–2012
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
Principal investigator · Terminated · Phase 1
University of North Carolina, Chapel Hill